Efficacy and tolerance of tenofovir in suboptimal responders to ADV or ADV/LAM treatment: 96 weeks results of the optib Italian multi center prospective open label study

Levrero, M.;Cimino, L.;Lampertico, P.;Viganò, M.;Gaeta, G.;Brancaccio, G.;Sagnelli, E.;Messina, V.;Raimondo, G.;Marzano, A.;Stefano, F.;Niro, G.;SANTANTONIO, TERESA ANTONIA;Puoti, M.;Di Marco, V.;Mazzella, G.;Di Costanzo, G.;Angelico, M.;Testoni, B.;Sava, C.

2011-01-01